 | • レポートコード：MRC23Q35870 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の染色体マイクロアレイ市場について調査・分析し、世界の染色体マイクロアレイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（cDNAマイクロアレイ、オリゴDNAマイクロアレイ、BACマイクロアレイ、SNPマイクロアレイ）、用途別セグメント分析（DNA検査、学術研究、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Bio-Rad Laboratories、MedGenome、Scott Minifab、Agilent Technologies、Perkin Elmer、Illumina、Microarrays、Merck KGaA、Arrayit Corporation、GE Healthcare、Molecular Devicesなどが含まれています。世界の染色体マイクロアレイ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、染色体マイクロアレイ市場規模を推定する際に考慮しました。本レポートは、染色体マイクロアレイの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、染色体マイクロアレイに関するビジネス上の意思決定に役立てることを目的としています。 ・染色体マイクロアレイ市場の概要 - 染色体マイクロアレイのタイプ別セグメント - 世界の染色体マイクロアレイ市場規模：タイプ別分析（cDNAマイクロアレイ、オリゴDNAマイクロアレイ、BACマイクロアレイ、SNPマイクロアレイ） - 染色体マイクロアレイの用途別セグメント - 世界の染色体マイクロアレイ市場規模：用途別分析（DNA検査、学術研究、その他） - 世界の染色体マイクロアレイ市場規模予測（2018年-2029年） ・染色体マイクロアレイ市場の成長トレンド - 染色体マイクロアレイの地域別市場規模（2018年-2029年） - 染色体マイクロアレイ市場ダイナミクス - 染色体マイクロアレイの業界動向 - 染色体マイクロアレイ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：cDNAマイクロアレイ、オリゴDNAマイクロアレイ、BACマイクロアレイ、SNPマイクロアレイ - 世界の染色体マイクロアレイのタイプ別市場規模（2018年-2023年） - 世界の染色体マイクロアレイのタイプ別市場規模（2024年-2029年） ・用途別セグメント：DNA検査、学術研究、その他 - 世界の染色体マイクロアレイの用途別市場規模（2018年-2023年） - 世界の染色体マイクロアレイの用途別市場規模（2024年-2029年） ・染色体マイクロアレイの地域別市場規模 - 北米の染色体マイクロアレイ市場規模（2018年-2029年） - アメリカの染色体マイクロアレイ市場規模（2018年-2029年） - ヨーロッパの染色体マイクロアレイ市場規模（2018年-2029年） - アジア太平洋の染色体マイクロアレイ市場規模（2018年-2029年） - 中国の染色体マイクロアレイ市場規模（2018年-2029年） - 日本の染色体マイクロアレイ市場規模（2018年-2029年） - 韓国の染色体マイクロアレイ市場規模（2018年-2029年） - インドの染色体マイクロアレイ市場規模（2018年-2029年） - オーストラリアの染色体マイクロアレイ市場規模（2018年-2029年） - 中南米の染色体マイクロアレイ市場規模（2018年-2029年） - 中東・アフリカの染色体マイクロアレイ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Bio-Rad Laboratories、MedGenome、Scott Minifab、Agilent Technologies、Perkin Elmer、Illumina、Microarrays、Merck KGaA、Arrayit Corporation、GE Healthcare、Molecular Devices ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Chromosome Microarray market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Chromosome Microarray is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Chromosome Microarray is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Chromosome Microarray in DNA Testing is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Chromosome Microarray include Thermo Fisher Scientific, Bio-Rad Laboratories, MedGenome, Scott Minifab, Agilent Technologies, Perkin Elmer, Illumina, Microarrays and Merck KGaA, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chromosome Microarray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chromosome Microarray.
The Chromosome Microarray market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chromosome Microarray market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chromosome Microarray companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
MedGenome
Scott Minifab
Agilent Technologies
Perkin Elmer
Illumina
Microarrays
Merck KGaA
Arrayit Corporation
GE Healthcare
Molecular Devices
Segment by Type
cDNA Microarrays
Oligo DNA Microarrays
BAC Microarrays
SNP Microarrays
Segment by Application
DNA Testing
Academic Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chromosome Microarray companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chromosome Microarray Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 cDNA Microarrays
1.2.3 Oligo DNA Microarrays
1.2.4 BAC Microarrays
1.2.5 SNP Microarrays
1.3 Market by Application
1.3.1 Global Chromosome Microarray Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 DNA Testing
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chromosome Microarray Market Perspective (2018-2029)
2.2 Chromosome Microarray Growth Trends by Region
2.2.1 Global Chromosome Microarray Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chromosome Microarray Historic Market Size by Region (2018-2023)
2.2.3 Chromosome Microarray Forecasted Market Size by Region (2024-2029)
2.3 Chromosome Microarray Market Dynamics
2.3.1 Chromosome Microarray Industry Trends
2.3.2 Chromosome Microarray Market Drivers
2.3.3 Chromosome Microarray Market Challenges
2.3.4 Chromosome Microarray Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chromosome Microarray Players by Revenue
3.1.1 Global Top Chromosome Microarray Players by Revenue (2018-2023)
3.1.2 Global Chromosome Microarray Revenue Market Share by Players (2018-2023)
3.2 Global Chromosome Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chromosome Microarray Revenue
3.4 Global Chromosome Microarray Market Concentration Ratio
3.4.1 Global Chromosome Microarray Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chromosome Microarray Revenue in 2022
3.5 Chromosome Microarray Key Players Head office and Area Served
3.6 Key Players Chromosome Microarray Product Solution and Service
3.7 Date of Enter into Chromosome Microarray Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chromosome Microarray Breakdown Data by Type
4.1 Global Chromosome Microarray Historic Market Size by Type (2018-2023)
4.2 Global Chromosome Microarray Forecasted Market Size by Type (2024-2029)
5 Chromosome Microarray Breakdown Data by Application
5.1 Global Chromosome Microarray Historic Market Size by Application (2018-2023)
5.2 Global Chromosome Microarray Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chromosome Microarray Market Size (2018-2029)
6.2 North America Chromosome Microarray Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chromosome Microarray Market Size by Country (2018-2023)
6.4 North America Chromosome Microarray Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chromosome Microarray Market Size (2018-2029)
7.2 Europe Chromosome Microarray Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chromosome Microarray Market Size by Country (2018-2023)
7.4 Europe Chromosome Microarray Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chromosome Microarray Market Size (2018-2029)
8.2 Asia-Pacific Chromosome Microarray Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chromosome Microarray Market Size by Region (2018-2023)
8.4 Asia-Pacific Chromosome Microarray Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chromosome Microarray Market Size (2018-2029)
9.2 Latin America Chromosome Microarray Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chromosome Microarray Market Size by Country (2018-2023)
9.4 Latin America Chromosome Microarray Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chromosome Microarray Market Size (2018-2029)
10.2 Middle East & Africa Chromosome Microarray Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chromosome Microarray Market Size by Country (2018-2023)
10.4 Middle East & Africa Chromosome Microarray Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Chromosome Microarray Introduction
11.1.4 Thermo Fisher Scientific Revenue in Chromosome Microarray Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Chromosome Microarray Introduction
11.2.4 Bio-Rad Laboratories Revenue in Chromosome Microarray Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 MedGenome
11.3.1 MedGenome Company Detail
11.3.2 MedGenome Business Overview
11.3.3 MedGenome Chromosome Microarray Introduction
11.3.4 MedGenome Revenue in Chromosome Microarray Business (2018-2023)
11.3.5 MedGenome Recent Development
11.4 Scott Minifab
11.4.1 Scott Minifab Company Detail
11.4.2 Scott Minifab Business Overview
11.4.3 Scott Minifab Chromosome Microarray Introduction
11.4.4 Scott Minifab Revenue in Chromosome Microarray Business (2018-2023)
11.4.5 Scott Minifab Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Chromosome Microarray Introduction
11.5.4 Agilent Technologies Revenue in Chromosome Microarray Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Detail
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer Chromosome Microarray Introduction
11.6.4 Perkin Elmer Revenue in Chromosome Microarray Business (2018-2023)
11.6.5 Perkin Elmer Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Chromosome Microarray Introduction
11.7.4 Illumina Revenue in Chromosome Microarray Business (2018-2023)
11.7.5 Illumina Recent Development
11.8 Microarrays
11.8.1 Microarrays Company Detail
11.8.2 Microarrays Business Overview
11.8.3 Microarrays Chromosome Microarray Introduction
11.8.4 Microarrays Revenue in Chromosome Microarray Business (2018-2023)
11.8.5 Microarrays Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Chromosome Microarray Introduction
11.9.4 Merck KGaA Revenue in Chromosome Microarray Business (2018-2023)
11.9.5 Merck KGaA Recent Development
11.10 Arrayit Corporation
11.10.1 Arrayit Corporation Company Detail
11.10.2 Arrayit Corporation Business Overview
11.10.3 Arrayit Corporation Chromosome Microarray Introduction
11.10.4 Arrayit Corporation Revenue in Chromosome Microarray Business (2018-2023)
11.10.5 Arrayit Corporation Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Detail
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Chromosome Microarray Introduction
11.11.4 GE Healthcare Revenue in Chromosome Microarray Business (2018-2023)
11.11.5 GE Healthcare Recent Development
11.12 Molecular Devices
11.12.1 Molecular Devices Company Detail
11.12.2 Molecular Devices Business Overview
11.12.3 Molecular Devices Chromosome Microarray Introduction
11.12.4 Molecular Devices Revenue in Chromosome Microarray Business (2018-2023)
11.12.5 Molecular Devices Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details